Jounce Therapeutics Inc

NASDAQ:JNCE  
8.15
+0.23 (+2.90%)
Equity Financing / Related, Initial Public Offerings

Jounce Therapeutics Announces Pricing Of $56.25 Mln Public Offering Of Common Stock

Published: 03/10/2021 07:10 GMT
Jounce Therapeutics Inc (JNCE) - Jounce Therapeutics Announces Pricing of $56.25 Million Public Offering of Common Stock.
Jounce Therapeutics - Priced an Underwritten Public Offering of 5,000,000 Shares of Common Stock at a Public Offering Price of $11.25 per Share.